| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Dec'17 |
|---|---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities: | |||||||||
Net loss | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Net loss | |||||||||
- | - | -1,086 | -1,170 | -952 | -683 | -665 | 0 | 0 | 0 |
Adjustments to reconcile net loss to net cash used in operating activities: | |||||||||
Depreciation and amortization | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Stock-based compensation and preference share liability | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Non-cash settlement of preference share liability | |||||||||
0 | - | - | - | - | - | - | - | - | - |
Allowance for doubtful accounts | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Employee benefit obligation | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Non-cash interest expense | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Deferred taxes | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Interest earned on cash and marketable securities held in Trust Account | |||||||||
- | - | 2,527 | 2,554 | 2,531 | 2,251 | 1,593 | 0 | 0 | 0 |
Interest receivable on cash and marketable securities held in Trust Account | |||||||||
- | - | 120 | 0 | 0 | 0 | - | - | - | - |
Change in operating assets and liabilities: | |||||||||
Trade receivables | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Other current assets | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Other long-term assets | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Receivable from related party | |||||||||
- | - | 0 | 0 | 0 | 0 | - | - | - | - |
Prepaid expenses | |||||||||
- | - | -98 | -150 | -98 | -59 | 110 | 0 | 0 | 0 |
Accounts payable | |||||||||
13,141 | 15,145 | 1,327 | 1,169 | -2,503 | 1,238 | 64 | 0 | 0 | 0 |
Accrued liabilities | |||||||||
- | - | 367 | 0 | 0 | 0 | - | - | - | - |
Other current liabilities | |||||||||
3,375 | 251 | -134 | 7 | 444 | 131 | 221 | 0 | 0 | 0 |
Deferred revenue | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Long-term liabilities | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Net cash used in operating activities | |||||||||
7,232 | 6,453 | -1,953 | -2,097 | -4,973 | -1,772 | -1,537 | 0 | 0 | 0 |
Cash Flows from Investing Activities: | |||||||||
Purchase of short-term investments | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Sale of short-term investments | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Purchase of property and equipment | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Sale of property and equipment | |||||||||
0 | - | - | - | - | - | - | - | - | - |
Capitalized software development costs | |||||||||
0 | - | - | - | - | - | - | - | - | - |
Purchase of intangible assets | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Restricted cash | |||||||||
- | - | - | - | - | - | - | - | - | 0 |
Investment of cash in Trust Account, net | |||||||||
- | - | - | - | - | - | 143,750 | 0 | 0 | 0 |
Cash withdrawn from Trust Account | |||||||||
- | - | - | 0 | 0 | 0 | - | - | - | - |
Net cash provided by investing activities | |||||||||
17,657 | 17,687 | 68,955 | 69,647 | 1,683 | -18,077 | -143,370 | 0 | 0 | 0 |
Cash Flows from Financing Activities: | |||||||||
Change in line of credit | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Borrowings on term loans | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Repayments on term loans | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Proceeds from sale of Units, net of underwriting discounts paid | |||||||||
- | - | - | - | - | - | 141,162 | 0 | 0 | 0 |
Proceeds from sale of Private Placement Units | |||||||||
- | - | - | - | - | - | 4,982 | 0 | 0 | 0 |
Proceeds from the sale of Founder Shares | |||||||||
- | - | - | - | - | - | - | 0 | 0 | 0 |
Repayment of promissory notes from related parties | |||||||||
- | - | - | - | - | - | - | - | - | 0 |
Payment of deferred offering costs | |||||||||
- | - | - | - | - | - | - | 0 | 0 | 0 |
Repurchase of common stock in connection with forward share purchase agreements | |||||||||
0 | - | - | - | - | - | - | - | - | - |
Payments related to forward share purchase agreements | |||||||||
0 | - | - | - | - | - | - | - | - | - |
Promissory notes issued in conjunction with extension | |||||||||
- | - | - | - | - | - | - | - | - | 0 |
Net cash provided by financing activities | |||||||||
6,335 | 4,702 | -67,129 | -68,106 | -11,474 | 6,405 | 145,505 | 0 | 0 | 0 |
Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Net increase (decrease) in cash, cash equivalents and restricted cash | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Supplemental disclosures of cash flow information: | |||||||||
Cash paid for interest | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Cash paid for income taxes | |||||||||
- | - | - | - | 0 | - | - | - | - | - |
Net change in cash and cash equivalents | |||||||||
- | - | - | 0 | 0 | -1,383 | - | 0 | 0 | 0 |
Non-cash financing activities: | |||||||||
Change in value of forward share purchase agreements | |||||||||
0 | - | - | - | - | - | - | - | - | - |
Common stock issued to settle a payable | |||||||||
0 | - | - | - | - | - | - | - | - | - |
Note payable issued to settle a payable | |||||||||
0 | - | - | - | - | - | - | - | - | - |
Change in value of common stock subject to possible redemption | |||||||||
- | - | -1,086 | -236 | -952 | -432 | -657 | 0 | 0 | 0 |